Abcam, ab248191, Anti-Ube4a antibody [EPR7331] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal UBE4A antibody. Carrier free. Suitable for ICC/IF, WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR7331,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Human,
Applications:ICC/IF, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab248191 is the carrier-free version of
ab128861
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Ube4a also known as U-box containing E3 ubiquitin protein ligase 4A plays a role in the ubiquitination process. It catalyzes the transfer of ubiquitin molecules to specific substrates tagging them for degradation by the proteasome. Ube4a has an approximate molecular mass of 121 kDa. Researchers have observed its expression in various tissues indicating a potential role in widespread cellular processes.
Biological function summary
Ube4a functions in the regulation of protein quality and turnover. It forms part of a ubiquitin-proteasome system playing an important role in maintaining protein homeostasis within cells. The regulation of protein levels is important for various cellular processes including cell cycle control and signal transduction. Ube4a engages in multi-subunit complexes interacting with other E3 ligases to facilitate substrate ubiquitination.
Pathways
Ube4a integrates into the ubiquitin-proteasome pathway a central component in protein degradation. This pathway is essential for regulating various cellular processes including responses to stress. Ube4a works alongside E1 activating enzymes and E2 conjugating enzymes to deliver ubiquitin to substrates efficiently. Its role within this pathway emphasizes the modulation of protein function and turnover linking it with other proteins like USP5 and UCH37 which are involved in deubiquitination.
Ube4a associates with certain neurological conditions and cancer. Researchers have linked aberrant ubiquitination to the pathology of these diseases indicating the importance of Ube4a in maintaining cellular balance. In neurodegenerative disorders improper Ube4a activity may disrupt protein degradation implicating proteins like Parkin. In some cancer types altered Ube4a expression can affect cell cycle regulation with downstream impacts on other proteins such as p53 highlighting its potential involvement in tumorigenesis.